Alivus Life Sciences Releases Sustainability Report Highlighting ESG Goals, Operational Scale for FY2025-26

Alivus Life Sciences Releases Sustainability Report Highlighting ESG Goals, Operational Scale for FY2025-26​

Alivus Life Sciences Limited, a company specializing in Active Pharmaceutical Ingredients (APIs), has released its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report details the entity's operational scale, commitment to environmental stewardship, social impact initiatives, and corporate governance practices.

The company maintains a strong focus on ethical operations while conducting business across national and international markets. Alivus serves over 75+ countries globally and has an established presence in more than 18 states and Union Territories within India. Its core business activities revolve around the manufacturing of chemical and pharmaceutical products, with 100.00% of its turnover derived from this segment.

Operational Scope and Workforce Details​

As of the financial year, Alivus Life Sciences reports a paid-up capital of `245.47 Million. The company employs a total workforce of 2,284, comprising employees and workers. Of these, 2,272 are permanent employees, with a significant majority being male (92.61%). The organization also includes 1,666 workers, primarily engaged in non-permanent roles.

In terms of market reach, the company is deeply embedded in the pharmaceutical value chain, providing APIs to over 700 clients and maintaining relationships with the top 20 generic pharmaceutical companies worldwide. Exports contribute a substantial 54.4% to the total turnover.

Environmental Stewardship and Resource Management​

Alivus Life Sciences has set ambitious sustainability targets, including achieving Water Neutrality by 2027 and Carbon Neutrality by 2030. The company's environmental management is supported by certifications, including ISO 14001:2015 for its Environmental Management System and ISO 45001:2018 for Occupational Health and Safety.

The company places high emphasis on resource efficiency in its manufacturing processes. For FY 2025-26, the total energy consumption was reported at 8,27,182.57 Gigajoules (GJ). Regarding water management, the total volume of water withdrawal stood at 3,67,993.82 kilolitres, with a total consumption of 3,42,187.82 kilolitres.

The company operates an integrated wastewater management system utilizing Effluent Treatment Plants (ETPs) and Sewage Treatment Plants (STPs). A significant effort is directed toward resource recovery, as the facility recycles treated water internally. Additionally, the organization processes its waste responsibly, generating 16,391.22 metric tonnes of total waste for the fiscal year. Over half of this quantity, specifically 13,593.61 metric tonnes, was recycled or reused through various processes.

Social Commitment and Human Rights​

The commitment to social responsibility is demonstrated through targeted CSR initiatives that focus on healthcare access and educational development. Key projects include:

• Access to Healthcare (Project Sampurna): This program supports pregnant women and children by improving nutritional standards and promoting hygiene practices, benefiting a total of 1,89,258 individuals.
• Access to Education (Project ViGyasa): Focused on cultivating scientific literacy among students in government-funded schools and colleges, this initiative benefited 23,705 students across 90 Schools and 6 Colleges.

In terms of human rights protection, the company ensures that all policies are designed to promote a respectful and inclusive environment. The organization has robust internal mechanisms, including the dedicated Safety Committee and the AI-enabled feedback platform AMBER, for addressing grievances related to workplace conditions and safety.

Governance and Oversight​

The report highlights the company's dedication to ethical conduct and governance integrity. The Board of Directors exercises strategic oversight over ESG matters, ensuring that practices align with stakeholder expectations and long-term sustainability objectives.

The quality of the sustainability information has been externally reviewed. The British Standards Institution (BSI) conducted a limited assurance engagement on several BRSR Core KPIs for FY 2025-26, including Green-house gas footprint, Water footprint, Energy footprint, and Enhancing Employee Wellbeing and Safety. BSI concluded that nothing came to their attention to suggest the sustainability information was not prepared in all material respects according to the agreed criteria.

The company also maintains a proactive approach to risk management, utilizing internal audits and structured processes overseen by senior management to address environmental, social, and governance (ESG) challenges across its operations and value chain.

ALIVUS Stock Price Movement​

Today, Alivus Life Sciences Limited saw its stock climb, posting a solid gain of 0.78% as it finished the day at ₹1393.6. The equity traded within an intraday range spanning from ₹1374.3 to ₹1418, with the share hitting its 52-week high during the session.